Literature DB >> 33557061

Third Generation Cephalosporin Resistant Enterobacterales Infections in Hospitalized Horses and Donkeys: A Case-Case-Control Analysis.

Anat Shnaiderman-Torban1, Dror Marchaim2,3, Shiri Navon-Venezia4,5, Ori Lubrani1, Yossi Paitan6,7, Haya Arielly6, Amir Steinman1.   

Abstract

In human medicine, infections caused by third-generation cephalosporin-resistant Enterobacterales (3GCRE) are associated with detrimental outcomes. In veterinary medicine, controlled epidemiological analyses are lacking. A matched case-case-control investigation (1:1:1 ratio) was conducted in a large veterinary hospital (2017-2019). In total, 29 infected horses and donkeys were matched to 29 animals with third-generation cephalosporin-susceptible Enterobacterales (3GCSE) infections, and 29 uninfected controls (overall n = 87). Despite multiple significant associations per bivariable analyses, the only independent predictor for 3GCRE infection was recent exposure to antibiotics (adjusted odds ratio (aOR) = 104, p < 0.001), but this was also an independent predictor for 3GCSE infection (aOR = 22, p < 0.001), though the correlation with 3GCRE was significantly stronger (aOR = 9.3, p = 0.04). In separated multivariable outcome models, 3GCRE infections were independently associated with reduced clinical cure rates (aOR = 6.84, p = 0.003) and with 90 days mortality (aOR = 3.6, p = 0.003). Klebsiella spp. were the most common 3GCRE (36%), and blaCTX-M-1 was the major β-lactamase (79%). Polyclonality and multiple sequence types were evident among all Enterobacterales (e.g., Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae). The study substantiates the significance of 3GCRE infections in equine medicine, and their independent detrimental impact on cure rates and mortality. Multiple Enterobacterales genera, subtypes, clones and mechanisms of resistance are prevalent among horses and donkeys with 3GCRE infections.

Entities:  

Keywords:  case–case–control; cephalosporins; equine; extended-spectrum β-lactamase; resistance

Year:  2021        PMID: 33557061      PMCID: PMC7913880          DOI: 10.3390/antibiotics10020155

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  59 in total

1.  Antimicrobial use and antimicrobial resistance in horses.

Authors:  J S Weese
Journal:  Equine Vet J       Date:  2015-11       Impact factor: 2.888

2.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.

Authors:  Neil Woodford; Elizabeth J Fagan; Matthew J Ellington
Journal:  J Antimicrob Chemother       Date:  2005-11-10       Impact factor: 5.790

3.  MDR ST2179-CTX-M-15 Escherichia coli co-producing RmtD and AAC(6')-Ib-cr in a horse with extraintestinal infection, Brazil.

Authors:  Lucianne Leigue; José F G Warth; Luana C Melo; Ketrin C Silva; Rodrigo A Moura; Leandro Barbato; Lais C Silva; Ana C M Santos; Rosa M Silva; Nilton Lincopan
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

Review 4.  Multidrug-resistant opportunistic pathogens challenging veterinary infection control.

Authors:  Birgit Walther; Karsten Tedin; Antina Lübke-Becker
Journal:  Vet Microbiol       Date:  2016-05-27       Impact factor: 3.293

5.  Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; Samira Masarwa; Sharon Tirosh-Levy; Amos Adler; Inna Chmelnitsky; Yehuda Carmeli; Eyal Klement; Amir Steinman
Journal:  Vet Microbiol       Date:  2012-11-26       Impact factor: 3.293

6.  Diseases in neonatal foals. Part 1: the 30 day incidence of disease and the effect of prophylactic antimicrobial drug treatment during the first three days post partum.

Authors:  F D Wohlfender; F E Barrelet; M G Doherr; R Straub; H P Meier
Journal:  Equine Vet J       Date:  2009-02       Impact factor: 2.888

7.  Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections.

Authors:  Nicole Gidaya Bonine; Ariel Berger; Arman Altincatal; Rosa Wang; Tarun Bhagnani; Patrick Gillard; Thomas Lodise
Journal:  Am J Med Sci       Date:  2018-11-22       Impact factor: 2.378

8.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Neonatal Foals: Prevalence, Risk Factors for Shedding and Association with Infection.

Authors:  Anat Shnaiderman-Torban; Yossi Paitan; Haia Arielly; Kira Kondratyeva; Sharon Tirosh-Levy; Gila Abells-Sutton; Shiri Navon-Venezia; Amir Steinman
Journal:  Animals (Basel)       Date:  2019-08-23       Impact factor: 2.752

9.  Prevalence of faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in veterinary hospital staff and students.

Authors:  Alexandra Royden; Emma Ormandy; Gina Pinchbeck; Ben Pascoe; Matthew D Hitchings; Samuel K Sheppard; Nicola J Williams
Journal:  Vet Rec Open       Date:  2019-01-07
View more
  3 in total

1.  Characterisation of and risk factors for extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX-M-1.

Authors:  Katariina Thomson; Katarina Eskola; Marjut Eklund; Kristiina Suominen; Merita Määttä; Jouni Junnila; Suvi Nykäsenoja; Kati Niinistö; Thomas Grönthal; Merja Rantala
Journal:  Acta Vet Scand       Date:  2022-02-09       Impact factor: 1.695

2.  Optimization of Veterinary Antimicrobial Treatment in Companion and Food Animals.

Authors:  Nikola Puvača
Journal:  Antibiotics (Basel)       Date:  2022-08-22

3.  Occurrence and Antimicrobial Susceptibility Profiles of Streptococcus equi subsp. zooepidemicus Strains Isolated from Mares with Fertility Problems.

Authors:  Francesca Paola Nocera; Elena D'Eletto; Monica Ambrosio; Filomena Fiorito; Ugo Pagnini; Luisa De Martino
Journal:  Antibiotics (Basel)       Date:  2021-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.